Raffles Medical Group has strong cash flow, and the group recommends paying a final dividend of 2.5 cents per share and plans to repurchase up to 100 million common shares in the next two years.

Under the influence of relevant news, the group's stock price rose sharply on Monday (February 24). As of press time, the stock price rose 5.5 points or 6.7% to 0.88 yuan, with a total trading volume of 5.15 million shares.

Raffles Medical Group announced its second half and full-year results for the end of December 31, 2024 on Monday. Net profit increased by 4.3% in the second half of the year to 31.6 million yuan, up from 30.3 million yuan in the same period last year. Revenue increased by 14.8% year-on-year, from 336.17 million yuan in the same period last year to 385.87 million yuan. The company announced a stock buyback plan on the same day.

The group also plans to pay a dividend of 2.5 cents per share. Due to strong cash flow, the group has also adjusted its dividend policy, paying at least 50% of its sustainable income each year as dividends.

Further reading

Raffles Medical Group's net profit increased by 4.3% in the second half of last year

Raffles Medical Group's net profit increased by 4.3% in the second half of last year

ASEAN medical tourism revenue grows rapidly, Singapore faces high cost challenges

ASEAN medical tourism revenue grows rapidly, Singapore faces high cost challenges